Navigation Links
BioSpecifics Technologies Corp. Announces Initiation of Global Phase 3 Trial of XIAFLEX® for Treatment of Peyronie's Disease
Date:10/12/2010

LYNBROOK, N.Y., Oct. 12 /PRNewswire/ -- BioSpecifics Technologies Corp. (Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced that its partner Auxilium Pharmaceuticals, Inc. (Auxilium) has dosed the first subject in the global Phase 3 program of XIAFLEX® (collagenase clostridium histolyticum) for the treatment of Peyronie's disease. Peyronie's disease is the development of scar tissue on the shaft of the penis that can cause the penis to curve during erection, often interfering with or preventing intercourse and resulting in psychological distress or bother for the patient. XIAFLEX is currently approved and marketed in the U.S. for the treatment of Dupuytren's contracture.

"The initiation of this Phase 3 trial is an important advance for XIAFLEX, moving it one step further as a treatment for Peyronie's disease. Currently, patients have only limited and undesirable treatment options available to them," commented Thomas L. Wegman, President of BioSpecifics. "We are very happy that XIAFLEX is progressing through the clinic as a second potential indication for the patients who could benefit immensely from a new treatment option. We look forward to these trial results next year."

Auxilium anticipates that it will complete enrollment for the double-blind studies in the first quarter of 2011 and will report top-line results in first half of 2012.

Auxilium has announced that the late stage global development plan for XIAFLEX will consist of four clinical studies and will be known by the acronym IMPRESS - The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies. There will be two randomized, double-blind, placebo-controlled Phase 3 studies, which are expected to enroll at least 600 patients at approximately 70 sites in the U.S. and Australia, with a 2:1 ratio of XIAFLEX to plac
'/>"/>

SOURCE BioSpecifics Technologies Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioSpecifics Technologies Corp. Announces Initiation of Phase IIb Trial for Peyronies Disease
2. BioSpecifics Technologies Corp. to Present at Cowen and Company 29th Annual Health Care Conference
3. BioSpecifics Technologies Corp. Announces XIAFLEX(TM) CORD I Study Published in New England Journal of Medicine
4. BioSpecifics Technologies Corp. Announces FDA Approval of XIAFLEX(TM) for Treatment of Dupuytrens Contracture
5. BioSpecifics Technologies Corp. to Present at the Piper Jaffray 21st Annual Health Care Conference
6. BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronies Disease
7. BioSpecifics Technologies Corp. to Present at Cowen and Company 30th Annual Health Care Conference
8. BioSpecifics Technologies Corp. to Host Conference Call to Report Fourth Quarter and Full Year 2009 Financial Results on March 10, 2010
9. BioSpecifics Technologies Corp. Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytrens Contracture
10. BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2009 Financial Results
11. BioSpecifics Technologies Corp. to Host Conference Call to Report First Quarter 2010 Financial Results on May 7, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 2015 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ... and six months ended June 30, 2015 and updated ... its earnings conference call this morning, August 4, 2015, ... can join the call by dialing (855) 582-8078. The ... , Year-to-date net revenues of $38.3 million, an increase ...
(Date:8/4/2015)...  Ironshore Pharmaceuticals & Development, Inc. ("Ironshore") has ... specializing in personalized medicine, to participate in the ... evaluate the safety and efficacy of HLD-200, a ... (ADHD). This is Restore,s second clinical trial program ... with Ironshore in 2014 and continues to work ...
(Date:8/3/2015)... Utah , Aug. 3, 2015  BC Technical, the ... acquired Ohio Valley Medical Systems, one of the largest ...  The addition of Ohio Valley Medical Systems allows BC ... include Hitachi MRI.   "We couldn,t be ... , President and CEO of BC Technical. "The Ohio ...
Breaking Medicine Technology:ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 2ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 3ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 4ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 5ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 6ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 7ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 8ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 9ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 10ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 11ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 12ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 13ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 14ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 15ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 16Restore Health Secures Another Clinical Trial with Ironshore Pharmaceuticals & Development 2BC Technical Acquires Ohio Valley Medical Systems 2
... 2012  Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the ... a company overview at Citi,s 2012 Global Health Care Conference ... the Waldorf Astoria in New York City. A ... the "Investors & Media" section of the Company,s Web site, ...
... Feb. 21, 2012   Enanta Pharmaceuticals, Inc. , ... best-in-class small molecule drugs in the infectious disease ... an exclusive collaboration and license agreement with Novartis ... its lead development candidate, EDP-239, from its NS5A ...
Cached Medicine Technology:Enanta Enters Into Strategic Collaboration to Advance NS5A Inhibitor Candidate for HCV 2Enanta Enters Into Strategic Collaboration to Advance NS5A Inhibitor Candidate for HCV 3
(Date:8/4/2015)... ... August 04, 2015 , ... They say a picture is ... health conditions, pictures and medical art can be essential. StayWell, a health solutions company, ... Krames Patient Education solutions have been used by physicians and other health care providers ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... today announced that Bruce McCalley joins its executive leadership team as Senior Vice ... sales success at technology companies and expanding global markets with a special emphasis ...
(Date:8/4/2015)... Denver, CO (PRWEB) , ... August 04, 2015 ... ... for skilled nursing homes and other long-term care facilities, today announced details of ... (QAPI) for nursing homes and centers. , Providigm’s QAPI Accreditation program , ...
(Date:8/4/2015)... ... August 04, 2015 , ... Data2Life , a Tel ... to provide pharmaceutical and healthcare organizations with advanced intelligence on drug effects. The ... regulatory filings (including the FDA and HealthCanada), social media and anonymized clinical electronic ...
(Date:8/4/2015)... ... August 04, 2015 , ... Half of consumers are considering ... is increasingly influential in their choice of practitioner, according to new survey data ... on Cosmetic Dermatologic Procedures reflects overall consumer views on cosmetic medical treatments and ...
Breaking Medicine News(10 mins):Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 2Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 3Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 2Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 3Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 2Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 3Health News:Data2Life Announces New System for Advance Intelligence on Drug Events 2Health News:Data2Life Announces New System for Advance Intelligence on Drug Events 3Health News:ASDS Survey: Half of Consumers Considering Cosmetic Procedure 2Health News:ASDS Survey: Half of Consumers Considering Cosmetic Procedure 3Health News:ASDS Survey: Half of Consumers Considering Cosmetic Procedure 4
... A unique global conference,focusing on the future ... - 10,2009. The HealthQuake Summit will present an ... and explore the ongoing and future seismic,"tremors" in ... policy, and,science/technology that will make the industry virtually ...
... for Passover, ATLANTA, April 14 As Americans ... Centers for Disease Control,and Prevention advises all travelers to ... a measles outbreak in Israel., Since September, more ... with about 700 cases in the cities of Jerusalem ...
... of needing to start treatment , , MONDAY, April 14 ... antioxidant urate in their blood appear to develop the symptoms ... a new report says. , The findings, published in the ... early laboratory studies about urate,s protective qualities and offer hope ...
... treated , , MONDAY, April 14 (HealthDay News) -- People ... headaches than those with normal blood pressure, a new ... the new research does not mean those with hypertension ... pressure medications. , The stiff arteries that are associated ...
... arthritis (RA) sufferers, the Medicare Prescription Drug Improvement ... better disease management with biologic drugs. Prior to ... of the tumor necrosis factor (TNF) inhibitors, ... brand name, Remicade. Since the MMA, most Medicare ...
... BMW NA, Henry Ford Health System, Kraft Foods ... VitalSpring Award-Winning,Health Benefits Solution to Drive Industry Standards ... HR and Benefits Executives is Scheduled for,April 22nd, ... for Wellness ROI,Inc. announced today that it has ...
Cached Medicine News:Health News:CDC Urges Travelers to Israel to Protect Themselves from Measles 2Health News:Elevated Urate Levels May Slow Parkinson's in Men 2Health News:High Blood Pressure May Be Buffer Against Headaches 2Health News:High Blood Pressure May Be Buffer Against Headaches 3Health News:Study details cost-effectiveness of rheumatoid arthritis treatments for Medicare recipients 2Health News:Study details cost-effectiveness of rheumatoid arthritis treatments for Medicare recipients 3Health News:Alliance for Wellness ROI, Inc. Selects VitalSpring as Exclusive Technology Partner 2Health News:Alliance for Wellness ROI, Inc. Selects VitalSpring as Exclusive Technology Partner 3
... Dynamics Corporation offers a quality ... infants to adults. Armboard covers ... material assuring easy cleaning while ... contamination. Choose from three options: ...
The Side Rail Socket fits all American-made tables with standard side rails. Fits accessories with flat mounting posts up to 1/4"W x 1"L. Attaches at rail ends or notches....
Stainless steel construction to withstand sterilization modalities (EtO, Steris®, and Sterrad®) Wide angle of view...
Stainless steel construction to withstand sterilization modalities (autoclave, EtO, Steris®, and Sterrad®) Fully autoclavable, with both distal and proximal ends uniquely soldered for longe...
Medicine Products: